Valorisation of GRP Dust Waste in Fired Clay Bricks

In Europe, the total amount of Glass Reinforced Plastic (GRP) waste is increasing. In order to valorise GRP dust (GRPd) waste and to reduce the consumption of nonrenewable resources in building materials, GRPd has been already investigated in cementitious materials where it gives even an improvement in some performances of the final products. Valorisation of GRPd waste in the production of bricks can be considered as a further alternative. In this paper, GRPd waste was substituted to the clay volume at 5% and 10% for the manufacturing of fired clay bricks. All specimens were subjected to a firing temperature of 850°C for 6 hours, then tested and compared in terms of porosity, compressive and flexural strengths, density, and water absorption. Despite a decrease in compressive strength up to 46% with 10% of GRPd substitution and an increase of water absorption from 14% to 29% with 5% and 10% of GRPd substitution, respectively, an increase in terms of lightness (about 10%), maximum flexural strength (up to 31%), and deflections at the maximum load (up to 130%) has been registered by specimens with 10% of GRPd substitution

Recycled Glass as Aggregate for Architectural Mortars

Abstract The possibility of recycling mixed colour waste glass as it is for manufacturing decorative architectural mortars, has been investigated. In mortars, the 0–33–66–100% of calcareous gravel volume has been replaced with recycled glass cullets, with no other inorganic addition. To mitigate the possible alkali–silica reaction, mixes with a hydrophobic admixture were also compared. The obtained results show that the replacement of calcareous gravel with glass cullets of similar grain size distribution permits to reduce the dosage of the superplasticizer admixture to obtain the same workability of fresh mortar; it does not affect significantly the mechanical performances, the water vapour permeability and the capillary water absorption but it reduces significantly the drying shrinkage deformation. The used recycled glass is classified as no reactive in terms of alkali–silica reaction neither in water nor in NaOH solution following the parameters of the current normative, even in the absence of the hydrophobic admixture. The hydrophobic admixture further delays the expansion trigger but not the speed of its propagation

Stainless and Galvanized Steel, Hydrophobic Admixture and Flexible Polymer-Cement Coating Compared in Increasing Durability of Reinforced Concrete Structures

The use of stainless or galvanized steel reinforcements, a hydrophobic admixture or a flexible polymer-cement coating were compared as methods to improve the corrosion resistance of sound or cracked reinforced concrete specimens exposed to chloride rich solutions. The results show that in full immersion condition, negligible corrosion rates were detected in all cracked specimens, except those treated with the flexible polymer-cement mortar as preventive method against corrosion and the hydrophobic concrete specimens. High corrosion rates were measured in all cracked specimens exposed to wet-dry cycles, except for those reinforced with stainless steel, those treated with the flexible polymer-cement coating as restorative method against reinforcement corrosion and for hydrophobic concrete specimens reinforced with galvanized steel reinforcements

Innovative hydraulic lime-based finishes with unconventional aggregates and TiO2 for the improvement of indoor air quality

This paper reports a study on 8 unconventional hydraulic lime-based mortars able to improve indoor air quality by acting as passive systems. Mortars have been prepared with commercial sand or highly adsorbent materials as aggregates with/without TiO2 as photocatalytic agent, to test also the decomposition of airborne pollutants. Mechanical properties, hygrometric behavior, inhibition of growth of molds and depollution properties have been tested. Despite using porous materials (zeolite and activated carbon), in mortars with unconventional aggregates, compressive strength is higher than in sand-based ones, with a more than double higher water vapor permeability. Zeolite-based mortars have the highest moisture buffering capacity followed by silica gel- and activated carbon-based mortars (1.5–2 times higher than reference, respectively, because of the high porosity of unconventional aggregates). Sand-based mortars show optimum inhibitory capacity against fungal growth. Concerning unconventional aggregates, silica gel mortars have good inhibitory capacity, whereas zeolite and activated carbon give to mortars an optimum substrate for molds. Mortars with unconventional aggregates as silica gel remove more than 80% of tracer pollutant after 2 h of test, whereas zeolite-based mortars remove the 65% of it after 120 min. TiO2 enhances depollution properties as photocatalytic oxidation agent when the mortar is close to saturation

An Immunological Analysis of Dystroglycan Subunits: Lessons Learned from a Small Cohort of Non-Congenital Dystrophic Patients

The dystroglycan (DG) expression pattern can be altered in severe muscular dystrophies. In fact, some congenital muscular dystrophies (CMDs) and limb-girdle muscular dystrophies (LGMDs) are caused by point mutations identified in six glycosyltransferase genes which are likely to target different steps along the posttranslational “O-glycosylation route” leading to a fully decorated and functional α-DG subunit. Indeed, hypoglycosylation of α-DG is thought to represent a major pathological event, in that it could reduce the DG’s ability to bind the basement membrane components, thus leading to sarcolemmal instability and necrosis. In order to set up an efficient standard immunological protocol, taking advantage of a wide panel of antibodies, we have analyzed the two DG subunits in a small cohort of adult dystrophic patients, whom an extensive medical examination had already clinically classified as affected by LGMD (5), Miyoshi (1) or distal (1) myopathy. Immunofluorescence analysis of skeletal muscle tissue sections revealed a proper sarcolemmal localization of the DG subunits in all the patients analyzed. However, Western blot analysis of lectin enriched skeletal muscle samples revealed an abnormal glycosylation of α-DG in two patients. Our work reinforces the notion that a careful immunological and biochemical analysis of the two DG subunits should be always considered as a prerequisite for the identification of new putative cases of dystroglycanopathy

effect of the type of surface treatment and cement on the chloride induced corrosion of galvanized reinforcements

The effect of a new passivation treatment, obtained by immersion of the galvanized reinforcements in a trivalent chromium salts based solution, on the chlorides induced corrosion has been investigated. To investigate also the effect of cement alkalinity on corrosion behaviour of reinforcements, concretes manufactured with three different European cements were compared. The obtained results show that the alternative treatment based on hexavalent chromium-free baths forms effective protection layers on the galvanized rebar surfaces. The higher corrosion rates of zinc coating in concrete manufactured with Portland cement compared to those recorded for bars in concrete manufactured with pozzolanic cement depends strongly on the higher chloride content at the steel concrete interface

ITALIAN CANCER FIGURES - REPORT 2015: The burden of rare cancers in Italy = I TUMORI IN ITALIA - RAPPORTO 2015: I tumori rari in Italia

OBJECTIVES: This collaborative study, based on data collected by the network of Italian Cancer Registries (AIRTUM), describes the burden of rare cancers in Italy. Estimated number of new rare cancer cases yearly diagnosed (incidence), proportion of patients alive after diagnosis (survival), and estimated number of people still alive after a new cancer diagnosis (prevalence) are provided for about 200 different cancer entities. MATERIALS AND METHODS: Data herein presented were provided by AIRTUM population- based cancer registries (CRs), covering nowadays 52% of the Italian population. This monograph uses the AIRTUM database (January 2015), which includes all malignant cancer cases diagnosed between 1976 and 2010. All cases are coded according to the International Classification of Diseases for Oncology (ICD-O-3). Data underwent standard quality checks (described in the AIRTUM data management protocol) and were checked against rare-cancer specific quality indicators proposed and published by RARECARE and HAEMACARE (www.rarecarenet.eu; www.haemacare.eu). The definition and list of rare cancers proposed by the RARECAREnet "Information Network on Rare Cancers" project were adopted: rare cancers are entities (defined as a combination of topographical and morphological codes of the ICD-O-3) having an incidence rate of less than 6 per 100,000 per year in the European population. This monograph presents 198 rare cancers grouped in 14 major groups. Crude incidence rates were estimated as the number of all new cancers occurring in 2000-2010 divided by the overall population at risk, for males and females (also for gender-specific tumours).The proportion of rare cancers out of the total cancers (rare and common) by site was also calculated. Incidence rates by sex and age are reported. The expected number of new cases in 2015 in Italy was estimated assuming the incidence in Italy to be the same as in the AIRTUM area. One- and 5-year relative survival estimates of cases aged 0-99 years diagnosed between 2000 and 2008 in the AIRTUM database, and followed up to 31 December 2009, were calculated using complete cohort survival analysis. To estimate the observed prevalence in Italy, incidence and follow-up data from 11 CRs for the period 1992-2006 were used, with a prevalence index date of 1 January 2007. Observed prevalence in the general population was disentangled by time prior to the reference date (≤2 years, 2-5 years, ≤15 years). To calculate the complete prevalence proportion at 1 January 2007 in Italy, the 15-year observed prevalence was corrected by the completeness index, in order to account for those cancer survivors diagnosed before the cancer registry activity started. The completeness index by cancer and age was obtained by means of statistical regression models, using incidence and survival data available in the European RARECAREnet data. RESULTS: In total, 339,403 tumours were included in the incidence analysis. The annual incidence rate (IR) of all 198 rare cancers in the period 2000-2010 was 147 per 100,000 per year, corresponding to about 89,000 new diagnoses in Italy each year, accounting for 25% of all cancer. Five cancers, rare at European level, were not rare in Italy because their IR was higher than 6 per 100,000; these tumours were: diffuse large B-cell lymphoma and squamous cell carcinoma of larynx (whose IRs in Italy were 7 per 100,000), multiple myeloma (IR: 8 per 100,000), hepatocellular carcinoma (IR: 9 per 100,000) and carcinoma of thyroid gland (IR: 14 per 100,000). Among the remaining 193 rare cancers, more than two thirds (No. 139) had an annual IR <0.5 per 100,000, accounting for about 7,100 new cancers cases; for 25 cancer types, the IR ranged between 0.5 and 1 per 100,000, accounting for about 10,000 new diagnoses; while for 29 cancer types the IR was between 1 and 6 per 100,000, accounting for about 41,000 new cancer cases. Among all rare cancers diagnosed in Italy, 7% were rare haematological diseases (IR: 41 per 100,000), 18% were solid rare cancers. Among the latter, the rare epithelial tumours of the digestive system were the most common (23%, IR: 26 per 100,000), followed by epithelial tumours of head and neck (17%, IR: 19) and rare cancers of the female genital system (17%, IR: 17), endocrine tumours (13% including thyroid carcinomas and less than 1% with an IR of 0.4 excluding thyroid carcinomas), sarcomas (8%, IR: 9 per 100,000), central nervous system tumours and rare epithelial tumours of the thoracic cavity (5%with an IR equal to 6 and 5 per 100,000, respectively). The remaining (rare male genital tumours, IR: 4 per 100,000; tumours of eye, IR: 0.7 per 100,000; neuroendocrine tumours, IR: 4 per 100,000; embryonal tumours, IR: 0.4 per 100,000; rare skin tumours and malignant melanoma of mucosae, IR: 0.8 per 100,000) each constituted <4% of all solid rare cancers. Patients with rare cancers were on average younger than those with common cancers. Essentially, all childhood cancers were rare, while after age 40 years, the common cancers (breast, prostate, colon, rectum, and lung) became increasingly more frequent. For 254,821 rare cancers diagnosed in 2000-2008, 5-year RS was on average 55%, lower than the corresponding figures for patients with common cancers (68%). RS was lower for rare cancers than for common cancers at 1 year and continued to diverge up to 3 years, while the gap remained constant from 3 to 5 years after diagnosis. For rare and common cancers, survival decreased with increasing age. Five-year RS was similar and high for both rare and common cancers up to 54 years; it decreased with age, especially after 54 years, with the elderly (75+ years) having a 37% and 20% lower survival than those aged 55-64 years for rare and common cancers, respectively. We estimated that about 900,000 people were alive in Italy with a previous diagnosis of a rare cancer in 2010 (prevalence). The highest prevalence was observed for rare haematological diseases (278 per 100,000) and rare tumours of the female genital system (265 per 100,000). Very low prevalence (<10 prt 100,000) was observed for rare epithelial skin cancers, for rare epithelial tumours of the digestive system and rare epithelial tumours of the thoracic cavity. COMMENTS: One in four cancers cases diagnosed in Italy is a rare cancer, in agreement with estimates of 24% calculated in Europe overall. In Italy, the group of all rare cancers combined, include 5 cancer types with an IR>6 per 100,000 in Italy, in particular thyroid cancer (IR: 14 per 100,000).The exclusion of thyroid carcinoma from rare cancers reduces the proportion of them in Italy in 2010 to 22%. Differences in incidence across population can be due to the different distribution of risk factors (whether environmental, lifestyle, occupational, or genetic), heterogeneous diagnostic intensity activity, as well as different diagnostic capacity; moreover heterogeneity in accuracy of registration may determine some minor differences in the account of rare cancers. Rare cancers had worse prognosis than common cancers at 1, 3, and 5 years from diagnosis. Differences between rare and common cancers were small 1 year after diagnosis, but survival for rare cancers declined more markedly thereafter, consistent with the idea that treatments for rare cancers are less effective than those for common cancers. However, differences in stage at diagnosis could not be excluded, as 1- and 3-year RS for rare cancers was lower than the corresponding figures for common cancers. Moreover, rare cancers include many cancer entities with a bad prognosis (5-year RS <50%): cancer of head and neck, oesophagus, small intestine, ovary, brain, biliary tract, liver, pleura, multiple myeloma, acute myeloid and lymphatic leukaemia; in contrast, most common cancer cases are breast, prostate, and colorectal cancers, which have a good prognosis. The high prevalence observed for rare haematological diseases and rare tumours of the female genital system is due to their high incidence (the majority of haematological diseases are rare and gynaecological cancers added up to fairly high incidence rates) and relatively good prognosis. The low prevalence of rare epithelial tumours of the digestive system was due to the low survival rates of the majority of tumours included in this group (oesophagus, stomach, small intestine, pancreas, and liver), regardless of the high incidence rate of rare epithelial cancers of these sites. This AIRTUM study confirms that rare cancers are a major public health problem in Italy and provides quantitative estimations, for the first time in Italy, to a problem long known to exist. This monograph provides detailed epidemiologic indicators for almost 200 rare cancers, the majority of which (72%) are very rare (IR<0.5 per 100,000). These data are of major interest for different stakeholders. Health care planners can find useful information herein to properly plan and think of how to reorganise health care services. Researchers now have numbers to design clinical trials considering alternative study designs and statistical approaches. Population-based cancer registries with good quality data are the best source of information to describe the rare cancer burden in a population

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field

Oxygen diffusion through hydrophobic cement-based materials

The oxygen diffusion coefficient through hydrophobic cement-based materials fully immersed in water was determined by potentiostatic measurements on concrete and by the use of a diffusion cell on cement pastes and mortars. The obtained results show that very high oxygen diffusion occurs through cement paste, mortar and concrete made with hydrophobic admixture as opposed to negligible diffusion through the reference cement matrix without admixture. Moreover, the oxygen diffusion coefficients measured through hydrophobic cement matrices immersed in water were comparable with those reported in literature for unsaturated cement materials in air. These experimental results appear to confirm that oxygen dissolved in water directly diffuses as a gaseous phase through the empty pores of a hydrophobic cement matrix. This could explain the severe corrosion of steel reinforcement embedded in cracked hydrophobic concrete immersed in an aqueous chloride solution observed in a previous work

Effect of low dosages of waste GRP dust on fresh and hardened properties of mortars: Part 2

Part 1 of the work reported that by replacing 5–10% of sand volume with GRP dust, workability, autogeneous shrinkage, deformability and total porosity, though with a smaller average radius, of mortars increased, thereby reducing significantly the mechanical performance, when wet curing conditions are adopted. However, the risk of cracking induced by restrained shrinkage and the capillary water absorption is lower in the presence of GRP dust, leading to enhanced durability of GRP mortars when used as supporting role. Therefore, in the present work, plaster mortars manufactured by replacing 0–2.5–5% of sand volume with GRP dust were characterized. For comparison, the addition of an hydrophobic admixture at different dosages was also considered. Permeability is not significantly reduced by the low addition of GRP dust, but it is slightly increased by silane addition. Thermal insulation properties, capillary water absorption and resistance to efflorescence are better with waste GRP dust addition, especially when combined with silane